These preliminary data confirm deferiprone monotherapy to be more effective than deferasirox in improving myocardial siderosis and a comparable efficacy between deferasirox and desferrioxamine.
Deferiprone or deferasirox for cardiac siderosis in ? thalassemia major. (reply)
Pepe Alessia;Rossi Giuseppe;
2011
Abstract
These preliminary data confirm deferiprone monotherapy to be more effective than deferasirox in improving myocardial siderosis and a comparable efficacy between deferasirox and desferrioxamine.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
prod_202670-doc_44992.pdf
solo utenti autorizzati
Descrizione: Deferiprone or deferasirox for cardiac siderosis
Dimensione
78.86 kB
Formato
Adobe PDF
|
78.86 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
